Recent advancements in single dose slow-release devices for prophylactic vaccines.
Sign Up to like & getrecommendations! Published in 2022 at "Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology"
DOI: 10.1002/wnan.1832
Abstract: Single dose slow-release vaccines herald a new era in vaccine administration. An ideal device for slow-release vaccine delivery would be minimally invasive and self-administered, making these approaches an attractive alternative for mass vaccination programs, particularly… read more here.
Keywords: single dose; dose slow; release; slow release ... See more keywords
How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-018-1710-6
Abstract: Over the last two decades, thrombolytic therapy (TT) has become an alternative to surgery as a first-line therapy in patients with thrombosed mechanical valves [1–3]. In TROIA Trial, low dose (25 mg)—slow infusion (6 h)… read more here.
Keywords: low dose; infusion; class; ultra slow ... See more keywords
An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism.
Sign Up to like & getrecommendations! Published in 2022 at "Current vascular pharmacology"
DOI: 10.2174/1570161120666220428095705
Abstract: BACKGROUND There is limited data on moderate-dose with slow-infusion thrombolytic regimen by ultrasound-asssisted-thrombolysis (USAT) in patients with acute pulmonary embolism (PE). AIMS In this study, our eight-year experience on USAT with moderate-dose, slow-infusion tissue-type plasminogen… read more here.
Keywords: dose slow; mortality; infusion; moderate dose ... See more keywords